Here are relevant reports on : neuropathic-pain-market
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024
The market for infusion pump software is expected to grow USD 1,044 million by 2024, at a CAGR of 7.1% during the forecast period. The major vendors in the global infusion pump software market are BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030
The elastomeric infusion pumps market is expected to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, at a CAGR of 5.3% during the forecast period. The report profiles key companies, including Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), and WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
ASEAN Infusion Pump Market by Product (Accessories (Dedicated (Volumetric Pumps, Insulin Pumps, Enteral Pumps) & Non-dedicated), Devices (Traditional, Specialty)), Application (Oncology, Diabetes, Pain Management), End User - Global Forecast to 2030
The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030
The global Compounding Pharmacy market, valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030
The global veterinary biologics market, valued at US$2.61 billion in 2024, stood at US$2.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2030, culminating in a forecasted valuation of US$3.51 billion by the end of the period. The market growth is fueled by increasing demand for effective animal therapeutics, rising populations of livestock and companion animals, and greater awareness of animal health and disease prevention.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Capnography Devices Market by Product [Capnograhs (Stand-Alone, Hand-Held, Multi-Parameter) & Disposables], Application (Procedural Sedation, Critical Care, Emergency Medicine, Pain Management) & End User (Hospital, Ambulatory) - Global Forecasts to 2019
Emerging markets such as China, India, and Brazil are offering high growth opportunities for companies engaged in the development and marketing of capnographs. Huge patient’s population base, rising incidences of diseases and increasing aging population, and Government initiatives to develop their healthcare facilities are the key factors propelling demand for capnographs in these emerging nations.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030
The global wearable healthcare devices market, valued at US$41.07 billion in 2024, stood at US$45.29 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$75.98 billion by the end of the period. Market growth is driven by rising health awareness, a shift toward preventive care, and the increasing prevalence of chronic conditions in aging populations.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Ablation Technology Market by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), Enduser (Hospital, ASC) & Region Global Forecasts to 2029
The global ablation technology market, valued at US$5.58 billion in 2023, stood at US$6.11 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$9.62 billion by the end of the period. The drivers for this market include expanding access to healthcare services, an increasing preference for minimally invasive treatments, and the use of ablation procedures in expanded application fields that fuel the ablation technology market growth.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Electrotherapy Market by Treatment Type (TSE, IC, PSWD, TENS, SCS, EA, PENS), Application (Sports Injury, Tissue Repair, Pain Management), By End User (Hospitals, Clinics, Rehabilitation Centres) - Global Forecast to 2022
The global electrotherapy market is expected to reach $1,076.1 Million by 2022 from $902.5 Million in 2017, growing at a CAGR of 4.0% from 2017 to 2022. Increasing incidences of diabetes; technological advancements in electrotherapy systems; increasing obesity; and rising number of sports injuries are some of the major driving factors driving the growth of the global electrotherapy market. However, lack of awareness about the usage of electrotherapy systems in developing countries; availability of large number of substitutes; and saturation in developed countries are hindering the growth of this market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
